Trials / Completed
CompletedNCT00318968
Nexium RESPONSE Trial
Development of an Algorithm for Identification of Responders to Short Term Treatment With Esomeprazole (Nexium) in Primary Care
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of the study is to develop, and test, an algorithm for identification of responders to empirical esomeprazole treatment in general practices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole |
Timeline
- Start date
- 2006-05-01
- Completion
- 2007-11-01
- First posted
- 2006-04-27
- Last updated
- 2009-01-26
Locations
38 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00318968. Inclusion in this directory is not an endorsement.